Home

about

who we are

Dedicated to Advancing Global Healthcare

At KYA-BRS, we lead the way in advancing clinical research and bioequivalence studies with a deep commitment to innovation, integrity, and global collaboration. Our state-of-the-art facilities and expert team work tirelessly to deliver precise, impactful results that improve healthcare outcomes worldwide.

At KYA-BRS, we are driven by a singular mission—to advance healthcare through innovative, ethical, and cutting-edge research. As Bangladesh's first contract research organization, we have set the standard for clinical trials and non-clinical studies in the region. Our unique affiliation with Khwaja Yunus Ali Medical College & Hospital allows us to combine clinical expertise with advanced research, delivering impactful results that contribute to the global healthcare landscape.

Since our inception, we have been at the forefront of medical research, conducting Phase I–III clinical trials and bioequivalence studies under international regulatory standards. Our 40,000 square feet facility is equipped with state-of-the-art laboratories and research spaces that allow us to perform detailed and precise studies across a wide range of therapeutic areas.

At the heart of KYA-BRS is a commitment to participant safety, scientific integrity, and clinical excellence. We take pride in being a trusted partner to both national and international organizations, contributing meaningfully to scientific discoveries that improve lives worldwide.

Our Journey Through Time

Explore the pivotal moments that have defined our path, from humble beginnings to becoming a leader in clinical research and innovation, shaping the future of healthcare every step of the way.

March 2010

history image

KYA-BRS was officially founded as the first contract research organization in Bangladesh, marking the beginning of a new era in clinical and non-clinical research.

July 2012

history image

Our state-of-the-art bioanalytical laboratory became operational, enabling us to conduct a wide range of complex bioequivalence and clinical studies.

September 2015

history image

Successfully completed our first Phase I clinical trial, paving the way for many more breakthroughs in clinical research and drug development.

November 2018

history image

Achieved accreditation from leading international regulatory bodies, further establishing our commitment to quality and compliance in clinical research.

April 2023

history image

Launched our newest technological advancements in clinical monitoring and data analysis, solidifying our position as a leader in global clinical research.

Why Partner with KYA-BRS?

At KYA-BRS, we combine industry expertise, advanced facilities, and a personalized approach to ensure high-quality, precise clinical research. With a commitment to global compliance and integrity, we deliver results that drive the success of your trials.

Unmatched Expertise

With decades of experience in clinical research, KYA-BRS is home to a team of skilled professionals who are experts in conducting Phase I-III clinical trials. Our deep understanding of various therapeutic areas allows us to deliver reliable, data-driven insights.

Advanced Facilities

Our 40,000-square-foot clinical trial facility is equipped with cutting-edge technology, including a bioanalytical lab, screening space, and clinical monitoring tools. This ensures that every trial is conducted under the most stringent standards, guaranteeing safety and precision.

Global Standards

KYA-BRS operates in compliance with international regulatory standards, ensuring that our studies meet global benchmarks for quality and safety. Our adherence to Good Clinical Practice (GCP) guidelines enables us to deliver trustworthy results.

Personalized Approach

We believe that every project is unique, which is why we offer tailored solutions to meet the specific needs of our clients. From clinical trial management to quality assurance, we provide customized support at every step to ensure the success of your research.

A call to reach out for collaborations, inquiries, or participation.